BioCentury | Nov 22, 2017
Clinical News

Researchers use RWE to reproduce trial results

...study commitments. Draft guidance is due by December 2021 (see BioCentury, Oct. 20) . Jaime De Leon Altace Kinzalmono Micardis Pritor ramipril Telmisartan telmisartan/amlodipine telmisartan/hydrochlorothiazide Pfizer...
BioCentury | Jun 10, 2013
Company News

Astellas, Boehringer Ingelheim sales and marketing update

...a small molecule angiotensin II receptor, and amlodipine, a calcium channel blocker, is approved as Twynsta...
BioCentury | Oct 18, 2010
Clinical News

Twynsta telmisartan/amlodipine regulatory update

...MAA from Boehringer Ingelheim for Twynsta telmisartan/amlodipine to treat hypertension. The company plans to launch Twynsta...
...launch Twynsta in Europe as soon as possible. Twynsta is already approved in the U.S. Twynsta...
...receptor, and amlodipine, a calcium channel blocker. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Twynsta telmisartan/amlodipine...
BioCentury | Oct 12, 2010
Company News

EC approves hypertension drug Twynsta

...approved an MAA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for Twynsta telmisartan/amlodipine to treat hypertension. Twynsta...
BioCentury | Sep 6, 2010
Clinical News

Twynsta telmisartan/amlodipine: Phase III data

...Phase III trial in 858 patients with severe hypertension, an 80/10 mg formulation of Twynsta telmisartan/amlodipine...
...alone (p=0.0002). Additionally, 46% of Twynsta-treated patients achieved a >=50 mmHg reduction in blood pressure. Twynsta...
...Twynsta for the indication (see BioCentury, July 26). Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Twynsta...
BioCentury | Jul 26, 2010
Clinical News

Twynsta telmisartan/amlodipine regulatory update

...for Twynsta telmisartan/amlodipine to treat hypertension. CHMP is part of the European Medicines Agency (EMA). Twynsta...
...receptor, and amlodipine, a calcium channel blocker. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Twynsta telmisartan/amlodipine...
BioCentury | Jul 24, 2010
Company News

CHMP backs Twynsta, reviews modified-release opioids

...on an MAA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for Twynsta telmisartan/amlodipine to treat hypertension. Twynsta...
BioCentury | Jan 4, 2010
Finance

4Q approvals

...Ingelheim GmbH EC approves Sifrol pramipexole to treat idiopathic Parkinson's disease (PD) FDA approves Twynsta telmisartan/amlodipine...
BioCentury | Dec 7, 2009
Clinical News

Micardis telmisartan regulatory update

...plc (LSE:GSK; NYSE:GSK, London, U.K.). Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Micardis telmisartan, telmisartan/hydrochlorothiazide, telmisartan/amlodipine...
BioCentury | Oct 26, 2009
Clinical News

Twynsta telmisartan/amlodipine regulatory update

...FDA approved an NDA from Boehringer for Twynsta telmisartan/amlodipine to treat hypertension as a single agent...
...for the product in Europe and Japan. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Twynsta telmisartan/amlodipine...
Items per page:
1 - 10 of 10